BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 33781143)

  • 1. Identification of the 11-lncRNA signatures associated with the prognosis of endometrial carcinoma.
    Wan J; Chen P; Zhang Y; Ding J; Yang Y; Li X
    Sci Prog; 2021; 104(1):368504211006593. PubMed ID: 33781143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of EMT-associated LncRNA Signature for Predicting the Prognosis of Patients with Endometrial Cancer.
    Shu W; Wang Z; Zhang W; Zhang J; Zhao R; Yu Z; Dong K; Wang H
    Comb Chem High Throughput Screen; 2023; 26(8):1488-1502. PubMed ID: 36200154
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A 7-lncRNA signature predict prognosis of Uterine corpus endometrial carcinoma.
    Ouyang D; Li R; Li Y; Zhu X
    J Cell Biochem; 2019 Oct; 120(10):18465-18477. PubMed ID: 31168849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma.
    Zhou M; Zhang Z; Zhao H; Bao S; Sun J
    BMC Cancer; 2018 Jan; 18(1):39. PubMed ID: 29304762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A three-lncRNA signature predicts overall survival and disease-free survival in patients with esophageal squamous cell carcinoma.
    Huang GW; Xue YJ; Wu ZY; Xu XE; Wu JY; Cao HH; Zhu Y; He JZ; Li CQ; Li EM; Xu LY
    BMC Cancer; 2018 Feb; 18(1):147. PubMed ID: 29409459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of an autophagy-related long-noncoding-RNA signature for endometrial cancer.
    Wang X; Dai C; Ye M; Wang J; Lin W; Li R
    Aging (Albany NY); 2021 Feb; 13(4):5104-5119. PubMed ID: 33534780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Clinical Outcome in Endometrial Carcinoma Based on a 3-lncRNA Signature.
    Ding H; Jiang F; Deng L; Wang J; Wang P; Ji M; Li J; Shi W; Pei Y; Li J; Zhang Y; Zhang Z; Chen Y; Li B
    Front Cell Dev Biol; 2021; 9():814456. PubMed ID: 35178403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a 6-lncRNA prognostic signature based on microarray re-annotation in gastric cancer.
    Ma B; Li Y; Ren Y
    Cancer Med; 2020 Jan; 9(1):335-349. PubMed ID: 31743579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
    Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
    World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prognostic model based on immune-related long noncoding RNAs for patients with epithelial ovarian cancer.
    Peng Y; Wang H; Huang Q; Wu J; Zhang M
    J Ovarian Res; 2022 Jan; 15(1):8. PubMed ID: 35031063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma.
    Zhou XY; Dai HY; Zhang H; Zhu JL; Hu H
    Biomed Res Int; 2022; 2022():2056913. PubMed ID: 35937391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-related lncRNAs as predictors of survival in breast cancer: a prognostic signature.
    Ma W; Zhao F; Yu X; Guan S; Suo H; Tao Z; Qiu Y; Wu Y; Cao Y; Jin F
    J Transl Med; 2020 Nov; 18(1):442. PubMed ID: 33225954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Function Analysis of a Five-Long Noncoding RNA Prognostic Signature for Endometrial Cancer Patients.
    Tang H; Wu Z; Zhang Y; Xia T; Liu D; Cai J; Ye Q
    DNA Cell Biol; 2019 Dec; 38(12):1480-1498. PubMed ID: 31539276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
    Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
    J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel epithelial-mesenchymal transition-related lncRNA signature predicts prognosis and immune status in endometrioid endometrial cancer.
    Jin Y; Qiu Y; Li Y; Jiang Z; Hu S; Dai H
    Medicine (Baltimore); 2023 Jun; 102(26):e34126. PubMed ID: 37390286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of an Immune-Related LncRNA Prognostic Signature in Uterine Corpus Endometrial Carcinoma Patients.
    Sun XX; Wen HQ; Zhan BX; Yang P
    Clin Lab; 2021 Nov; 67(11):. PubMed ID: 34758230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of a seven cuproptosis-associated lncRNA signature to predict the prognosis of endometrial cancer.
    Cai L; Cai L; Zhou L; Zhao Y; Qian J
    J Int Med Res; 2023 Dec; 51(12):3000605231213435. PubMed ID: 38102991
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prognostic 11 long noncoding RNA expression signature for breast invasive carcinoma.
    He Y; Li X; Meng Y; Fu S; Cui Y; Shi Y; Du H
    J Cell Biochem; 2019 Oct; 120(10):16692-16702. PubMed ID: 31095790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification and Validation of Six Autophagy-related Long Non-coding RNAs as Prognostic Signature in Colorectal Cancer.
    Cheng L; Han T; Zhang Z; Yi P; Zhang C; Zhang S; Peng W
    Int J Med Sci; 2021; 18(1):88-98. PubMed ID: 33390777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.